Concurrent chemoradiotherapy versus radiotherapy alone after induction chemoimmunotherapy for stage III NSCLC patients who did not undergo surgery: a single institution retrospective study
Abstract Background With remarkable success and few side effects, induction chemoimmunotherapy has been used to improve the prognosis of patients with resectable or potentially resectable non-small cell lung cancer (NSCLC), even in stage III disease. However, for patients who are medically inoperabl...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2023-07-01
|
| Serie: | Radiation Oncology |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s13014-023-02305-5 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|